RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 171 filers reported holding RELAY THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,786 | -32.7% | 19,713 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $246,314 | -18.9% | 19,611 | +6.4% | 0.00% | 0.0% |
| Q1 2023 | $303,592 | -3.0% | 18,433 | -12.0% | 0.00% | 0.0% |
| Q4 2022 | $312,993 | -20.6% | 20,950 | +19.1% | 0.00% | -50.0% |
| Q3 2022 | $394,000 | +37.8% | 17,595 | +3.2% | 0.00% | +100.0% |
| Q2 2022 | $286,000 | -60.7% | 17,057 | -29.9% | 0.00% | -50.0% |
| Q1 2022 | $728,000 | -22.2% | 24,327 | -20.2% | 0.00% | 0.0% |
| Q4 2021 | $936,000 | +8.0% | 30,500 | +10.9% | 0.00% | 0.0% |
| Q3 2021 | $867,000 | -25.5% | 27,495 | -13.5% | 0.00% | -33.3% |
| Q2 2021 | $1,163,000 | +36.2% | 31,786 | +28.7% | 0.00% | 0.0% |
| Q1 2021 | $854,000 | -2.2% | 24,706 | +17.6% | 0.00% | 0.0% |
| Q4 2020 | $873,000 | – | 21,014 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 3,030,648 | $45,277,881 | 3.51% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $416,900,147 | 3.48% |
| Finepoint Capital LP | 714,848 | $10,680 | 3.45% |
| Nextech Invest Ltd. | 475,485 | $7,103,746 | 2.83% |
| BVF INC/IL | 3,876,021 | $57,907,754 | 2.44% |
| Integral Health Asset Management, LLC | 625,000 | $9,337,500 | 1.96% |
| EcoR1 Capital, LLC | 4,163,824 | $62,207,531 | 1.89% |
| Boxer Capital, LLC | 2,169,132 | $32,406,832 | 1.71% |
| BRANDYWINE MANAGERS, LLC | 31,807 | $475,197 | 1.66% |
| HighVista Strategies LLC | 176,521 | $2,637,224 | 1.57% |